Abstract Expression of the receptor tyrosine kinase HER3 is negatively correlated with survival in ovarian cancer, and HER3 overexpression is associated with cancer progression and therapeutic resistance. Thus, improvements in HER3-targeted therapy could lead to significant clinical impact for ovarian cancer patients. Previous work from our group established multivalency as a potential strategy to improve the therapeutic efficacy of HER3-targeted ligands, including affibodies....
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Lack of standard definitions of primary and secondary (non)responders after RYGB and SG makes it impossible to compare the litera...
-
We aimed (1) to describe the characteristics of patient–ventilator asynchrony in a population of critically ill children, (2) to describe th...
-
http://bit.ly/2QRG1lG
-
AbstractIntroductionVascular trauma data have been submitted to the American Association for the Surgery of Trauma PROspective Observational...
-
The NCH Healthcare System launched a "virtual visit" program, enabling patients to have a telemedicine visit any time of day or ni...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου